Hollow Microneedle Technology

3M™ Hollow Microstructured Transdermal System (hMTS)


Dedicated to Reproducible Delivery

  • When you develop life-saving drugs, you have serious skin in the game. 3M’s hMTS System is designed to help your biologic formulation push past barriers, and reach its intended destination. 

Let us help you take on cancer

  • It’s time to approach clinical trials with confidence. We have a device designed to consistently and reproducibly deliver your cancer vaccine to the patient’s dermis. 3M Hollow Microstructured Transdermal System (hMTS) is designed to help your biologic formulation break through skin barriers and potentially achieve your clinical objectives. 

Steps to Clinical Readiness

  • In leading up to the finalized 3M Hollow Microstructured Transdermal System design. 3M has applied a rigorous process including:

    • Conducting a human tolerability study
    • Finalizing the device design
    • Manufacturing critical components from medical grade materials
    • Establishing GMP array manufacturing and device assembly
    • Filing documentation with FDA

Expand the Range of Deliverable Biologics

  • Expand Range

    While drug PK profiles need to be evaluated on an individual basis, microneedle delivery via 3M™ Hollow Microstructured Delivery System may offer potential benefits when compared with conventional injections2:

    • Faster absorption
    • Higher bioavailability of drugs
    • Higher peak blood levels
    • Reproducible intradermal delivery
    • Intradermal administration of larger volumes (0.5 mL to 2 mL) over a range of viscosities

    2 3M, data on file.

  • Product in development. Not available for commercial sale.